Finance

Lists
6855:HKG
Ascentage Pharma Group International
HK$31.70
+7.24%
(+2.14) 1D
Sep 21, 4:08:34 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6855...
Open
HK$29.80
High
HK$31.88
Low
HK$29.80
Mkt. cap
11.84B
Avg. vol.
0.00
Volume
4.28M
52-wk high
HK$79.30
52-wk low
HK$29.36
EPS
-HK$4.62
No. of employees
828
Open
HK$29.80
High
HK$31.88
Low
HK$29.80
Mkt. cap
11.84B
Avg. vol.
0.00
Volume
4.28M
52-wk high
HK$79.30
52-wk low
HK$29.36
EPS
-HK$4.62
No. of employees
828
About Ascentage Pharma Group International
CEODajun Yang
Employees828
Founded2009
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
170.21M
170.21M
151.11M
151.11M
Cost of goods sold
13.64M
13.64M
5.86M
5.86M
Cost of revenue
13.64M
13.64M
5.86M
5.86M
Research and development expenses
304.44M
304.44M
348.73M
348.73M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
181.22M
181.22M
172.64M
172.64M
Operating expense
485.67M
485.67M
521.37M
521.37M
Total operating expenses
499.31M
499.31M
527.23M
527.23M
Operating income
-329.10M
-329.10M
-376.13M
-376.13M
Other non operating income
-2.99M
-2.99M
-30.14M
-30.14M
EBT including unusual items
-325.37M
-325.37M
-401.69M
-401.69M
EBT excluding unusual items
-324.79M
-324.79M
-401.69M
-401.69M
Income tax expense
714.00K
714.00K
6.81M
6.81M
Effective tax rate
-0.22%
-0.22%
-1.70%
-1.70%
Other operating expenses
-
-
-
-
Net income
-326.00M
-326.00M
-408.35M
-408.35M
Net profit margin
-191.53%
-191.53%
-270.24%
-270.24%
Earnings per share
-
-
-
-
Interest and investment income
25.36M
25.36M
18.00M
18.00M
Interest expense
-13.14M
-13.14M
-13.41M
-13.41M
Net interest expenses
12.22M
12.22M
4.59M
4.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-310.96M
-310.96M
-356.97M
-356.97M
Gain or loss from assets sale
-333.50K
-333.50K
-
-
AI content may include mistakes. Learn more
Google apps